These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33627362)

  • 1. An intersectional human rights approach to prioritising access to COVID-19 vaccines.
    Sekalala S; Perehudoff K; Parker M; Forman L; Rawson B; Smith M
    BMJ Glob Health; 2021 Feb; 6(2):. PubMed ID: 33627362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equitable COVID-19 Vaccine Access.
    Torreele E; Amon JJ
    Health Hum Rights; 2021 Jun; 23(1):273-288. PubMed ID: 34194219
    [No Abstract]   [Full Text] [Related]  

  • 3. Ethical limits to placebo use and access to Covid-19 vaccines as a human right.
    Greco DB
    Indian J Med Ethics; 2021; VI(2):1-14. PubMed ID: 33908350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why should HCWs receive priority access to vaccines in a pandemic?
    Symons X; Matthews S; Tobin B
    BMC Med Ethics; 2021 Jun; 22(1):79. PubMed ID: 34176474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prioritisation of ICU treatments for critically ill patients in a COVID-19 pandemic with scarce resources.
    Leclerc T; Donat N; Donat A; Pasquier P; Libert N; Schaeffer E; D'Aranda E; Cotte J; Fontaine B; Perrigault PF; Michel F; Muller L; Meaudre E; Veber B
    Anaesth Crit Care Pain Med; 2020 Jun; 39(3):333-339. PubMed ID: 32426441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccine against covid-19: an open question.].
    Busca MT
    Recenti Prog Med; 2021 Mar; 112(3):167-170. PubMed ID: 33687352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human rights and fair access to COVID-19 vaccines: the International AIDS Society-Lancet Commission on Health and Human Rights.
    Commissioners of and collaborators with the International AIDS Society–Lancet Commission on Health and Human Rights
    Lancet; 2021 Apr; 397(10284):1524-1527. PubMed ID: 33773117
    [No Abstract]   [Full Text] [Related]  

  • 8. The continued use of placebo arms in COVID-19 vaccine trials does not adequately protect the well-being of participants.
    Haire B
    Indian J Med Ethics; 2021; VI(2):1-10. PubMed ID: 33908354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covid-19 vaccine passports: access, equity, and ethics.
    Osama T; Razai MS; Majeed A
    BMJ; 2021 Apr; 373():n861. PubMed ID: 33795260
    [No Abstract]   [Full Text] [Related]  

  • 10. Tackling inequitable distribution of the COVID-19 vaccine.
    Mendes A
    Br J Community Nurs; 2021 Jan; 26(1):48-49. PubMed ID: 33356933
    [No Abstract]   [Full Text] [Related]  

  • 11. Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine.
    Sekalala S; Forman L; Hodgson T; Mulumba M; Namyalo-Ganafa H; Meier BM
    BMJ Glob Health; 2021 Jul; 6(7):. PubMed ID: 34253631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Vaccine, TRIPS, and Global Health Diplomacy: India's Role at the WTO Platform.
    Chattu VK; Singh B; Kaur J; Jakovljevic M
    Biomed Res Int; 2021; 2021():6658070. PubMed ID: 34485525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hard choices: Ethical challenges in phase 1 of COVID-19 vaccine roll-out in South Africa.
    Moodley K; Blockman M; Pienaar D; Hawkridge AJ; Meintjes J; Davies MA; London L
    S Afr Med J; 2021 Mar; 111(6):554-558. PubMed ID: 34382565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A matter of priority: equitable access to COVID-19 vaccines.
    Holzer F; Luna F; Manriquez T; Biller-Andorno N
    Swiss Med Wkly; 2021 Mar; 151():w20488. PubMed ID: 33715145
    [No Abstract]   [Full Text] [Related]  

  • 15. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
    So AD; Woo J
    BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A conceptual approach to the rationale for SARS-CoV-2 vaccine allocation prioritisation.
    Kohns Vasconcelos M; Marazia C; Koniordou M; Fangerau H; Drexler I; Afum-Adjei Awuah A
    Pathog Glob Health; 2021 Jul; 115(5):273-276. PubMed ID: 34107233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problematic Covid-19 vaccine trials in times of vaccine nationalism.
    Ravinetto R
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ensuring the global COVID-19 vaccine equity: Universal vaccine access strategy in the context of low and-middle-income countries.
    Parray AA; Yadav UN; Das A; Ali AM; Mollick S; Saha S; Mistry SK
    Glob Public Health; 2022 Apr; 17(4):614-621. PubMed ID: 35050840
    [No Abstract]   [Full Text] [Related]  

  • 19. "No" to placebo-controlled trials of Covid-19 vaccines.
    Ahmad A; Dhrolia MF
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Scientists' Collective 10-point proposal for equitable and timeous access to COVID-19 vaccine in South Africa.
    Gray G; Van der Heever A; Madhi SS; McIntyre J; Kana B; Stevens W; Sanne I; Richards G; Abdullah F; Mendelson M; Dasoo A; Nel J; Wulfsohn A; Blumberg L; Venter F
    S Afr Med J; 2020 Dec; 0(0):13163. PubMed ID: 33334389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.